Technology & innovation

This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.

Holding a nasal spray, for article on prehospital stroke nasal spray

Hong Kong researchers develop world-first nasal spray for stroke, cutting damage 80%

By / / Good News For Humankind

A nasal spray for stroke, developed at the University of Hong Kong, cut brain damage by more than 80% when given within 30 minutes of an ischemic stroke in preclinical studies. The idea is beautifully simple: tiny particles travel from the nose directly along nerve pathways to the brain, sidestepping the blood-brain barrier that derails most neurological drugs. Designed to be as easy to use as an EpiPen, it could let a bystander start protecting brain cells before the ambulance even arrives. Clinical trials are still years away, but if it holds up, this kind of “protection-first” thinking could reshape emergency care for stroke patients everywhere — especially the 85% who currently never reach treatment in time.

Flexbase redox flow battery in Switzerland, for article on redox flow battery

Switzerland begins work on the world’s most powerful redox flow battery

By / / Good News For Humankind

A redox flow battery rising from a 27-meter pit in northern Switzerland will become the world’s most powerful, capable of running 210,000 homes for a full day once it comes online in 2029. Unlike the lithium-ion batteries in our phones, this one stores energy in two liquid electrolytes pumped through a membrane — a design that’s non-flammable, almost fully recyclable, and built to cycle indefinitely without wearing out. It can respond to grid swings in milliseconds, soaking up excess wind power and releasing it when nearby AI data centers need a steady surge. Projects like this hint at what a renewables-first grid actually looks like: not just cleaner generation, but storage patient and powerful enough to make wind and solar genuinely dependable.

Scientist filling tubes, for article on reversible male contraception

Cornell researchers achieve first reversible male birth control in mice

By / / Good News For Humankind

Reversible male birth control just cleared a major hurdle: in a new Cornell study, male mice stopped producing sperm entirely after three weeks of treatment, then bounced back to full fertility within six weeks of stopping. The approach skips hormones altogether, targeting a specific window of sperm development in the testis so libido and other traits stay untouched. Even better, the mice went on to father healthy pups who were themselves fertile. The researchers are now testing new molecular targets and hope to launch a company within two years to move toward human trials. If the science holds up across species, it could finally give men a real long-acting option — and ease a contraceptive burden women have shouldered alone for generations.

Medical researcher in a lab examining vials related to asthma and COPD treatment and mRNA vaccine development, for article on benralizumab injection, for article on mRNA lung cancer vaccine

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

By / / Good News For Humankind

Benralizumab, a single injection given during an asthma or COPD attack, outperformed the steroid pills that have been the only emergency option since the 1970s. In a King’s College London trial of 158 patients, those who got the shot had four times fewer treatment failures over 90 days, along with easier breathing and fewer follow-up visits. Because steroids carry real risks with repeated use — diabetes, osteoporosis, and more — a genuine alternative could change daily life for millions of people who live in fear of the next flare-up. After a half-century of stalled progress on diseases that claim 3.8 million lives a year, this feels like the door finally opening.

Researcher examining brain scan imagery for an article about Alzheimer's prevention trial results

U.S. researchers cut Alzheimer’s risk by half in first-ever prevention trial

By / / Good News For Humankind

Alzheimer’s prevention may have reached a turning point after a landmark trial showed that removing amyloid plaques before symptoms appear can cut the risk of developing the disease by roughly 50%. Researchers at Washington University School of Medicine studied people with rare genetic mutations that make Alzheimer’s nearly inevitable, finding that early, aggressive treatment can genuinely alter the disease’s course. The results, published in The Lancet Neurology, mark the first time any intervention has shown potential to prevent Alzheimer’s from appearing at all, not merely slow its progression. That distinction matters enormously, since amyloid begins accumulating in the brain two decades before symptoms emerge.

A researcher examining brain scan imaging for an article about Parkinson's stem cell treatment — 14 words.

Japan approves world’s first Parkinson’s stem cell treatment to restore brain function

By / / Good News For Humankind

Japan’s Parkinson’s stem cell treatment has reached a landmark milestone after the country approved the world’s first iPSC-based therapy for the disease, offering real hope to an estimated 10 million patients globally. Developed by researchers at Kyoto University, the treatment transplants lab-grown dopamine-producing neurons directly into patients’ brains to replace those destroyed by Parkinson’s. Unlike existing medications that only manage symptoms, this approach attempts to restore the underlying neural machinery. Early trials showed measurable improvements in motor function, and Japan’s conditional approval now opens a genuine clinical pathway that simply did not exist before.

A researcher examining a vial in a medical laboratory for an article about Type 1 diabetes cure research

Stanford researchers take a major step toward curing Type 1 diabetes

By / / Good News For Humankind

Type 1 diabetes cure research took a significant step forward as Stanford University scientists demonstrated a hybrid approach combining gene therapy and immune system retraining to protect insulin-producing beta cells. Rather than simply replacing destroyed cells, the method attempts to retrain the immune system to stop attacking them — targeting the root cause of the disease. In preclinical animal trials, the approach restored normal blood sugar regulation without requiring lifelong immunosuppressant drugs. For the millions living with this demanding, costly condition, the findings represent meaningful progress toward a functional cure.

Colorful coral reef with tropical fish in clear blue water for an article about Mauritius coral restoration

Mauritius pioneers heat-resistant coral with 98% survival rates

By / / Good News For Humankind

Coral restoration in Mauritius is delivering results that are turning heads across the marine science world. Researchers working with the Mauritius Oceanography Institute have achieved a 98% survival rate for transplanted coral fragments by using heat-stress conditioning, a technique that trains coral to withstand the warming temperatures climate change is already producing. That figure dwarfs the global average of 60-70% for conventional transplant methods. With the Indian Ocean having suffered significant reef loss in recent decades, this approach offers a replicable model that neighboring island nations are already watching closely.

A glowing plasma ring inside a fusion tokamak reactor for an article about commercial fusion power

Fusion power achieves commercial viability for the first time

By / / Archive of Human Genius

Commonwealth Fusion Systems’ Arc-3 reactor in Devens, Massachusetts began delivering electricity to the New England grid in 2039 at 4.2 cents per kilowatt-hour, after high-temperature superconducting magnets developed between 2026 and 2031 allowed the plasma chamber to shrink to one-tenth the volume previously required. Successive iterations of the SPARC pilot reactor, funded through a 2027 federal-private partnership, validated sustained net-energy gain across thousands of operational hours before Arc-3 entered commercial service. Within eighteen months of grid connection, three coal-dependent regions in the American Midwest and two in South Korea had retired their remaining fossil fuel plants entirely, eliminating an estimated 14,000 premature deaths annually from air pollution.

Close-up of a researcher examining brain scan imagery for an article about Alzheimer's reversal in mice

American scientists fully reverse Alzheimer’s in mice in a promising study

By / / Good News For Humankind

Alzheimer’s reversal in mice has been achieved by a team of American researchers who eliminated amyloid plaques and tau tangles while restoring measurable memory and spatial reasoning in treated animals. Using precision gene therapy to suppress overactive neurodegeneration pathways, the team reduced brain inflammation and reactivated neurons that had gone functionally silent. The findings matter because no existing treatment reverses Alzheimer’s — they only slow it. What makes this significant is that recovery, not merely stabilization, was observed, challenging longstanding assumptions about irreversible brain damage and strengthening the case that neuroplasticity could become a realistic therapeutic target.